Synexus appoints Paul McCluskey as Chief Financial Officer
18 September 2006
Paul, aged 42, was the European Managing Director of the formerly autonomous subsidiary of RHM plc, RHM Ingredients Ltd, which was acquired by private American owners. He is a fellow of the Institute of Chartered Accountants and previously held finance positions with BAE Systems plc and GlaxoSmithKline plc.
Michael Fort, CEO of Synexus, commented:
'We are delighted to have attracted Paul to Synexus. He has considerable experience of managing acquisitions and integrating those operations into a unified business. Synexus' strategy is to build, through targeted acquisitions, an international patient recruitment capability to manage large numbers of clinical trial patients for pharmaceutical clients. His experience in integrating businesses, systems and management teams will strengthen the company's overall capabilities as it continues to expand.'